EL-07 is an active drug and metabolised by CYP2C19. 26% of the population are classified as CYP2C19 poor metabolisers.
In these patients, the standard dose of EL-07 is likely to result in:

Question

EL-07 is an active drug and metabolised by CYP2C19.  26% of the population are classified as CYP2C19 poor metabolisers. In these patients, the standard dose of EL-07 is likely to result in:

Accepted Answer

increased risk of side effects such as arrhythmia

Answer

worsening of depression symptoms with increased risk of arrhythmia

Answer

reduced effectiveness and reduced risk of side effects such as arrhythmia

Answer

improvement in depression symptoms with no increased risk of arrhythmia

Crowdly

EL-07 is an active drug and metabolised by CYP2C19. 26% of the population are ...

Хочете миттєвий доступ до всіх перевірених відповідей на learning.monash.edu?